Complete characterization of synthetic peptides requires orthogonal analytical methods that confirm identity, purity, and secondary/tertiary structure. This guide covers the four primary techniques used in modern peptide characterization.

1. Mass Spectrometry (MS)

Techniques for Peptide Analysis

Method	Mass Range	Resolution	Sensitivity	Application
ESI-MS	<10 kDa	0.1 Da	pmol	Identity confirmation
MALDI-TOF	<50 kDa	0.1 Da	fmol	Quick mass check
LC-MS/MS	<5 kDa	0.01 Da	fmol	Sequencing, PTM
MALDI-TOF/TOF	<10 kDa	0.01 Da	fmol	De novo sequencing

ESI-MS (Electrospray Ionization)

Principle: Peptides are ionized from solution, producing multiply charged ions [M+nH]^(n+). Deconvolution yields the neutral mass.

Sample preparation:

1. Dissolve peptide in 50% MeCN/0.1% FA (0.1 mg/mL)
2. Infuse at 5–10 µL/min into ESI source
3. Acquire m/z 300–2000

Deconvolution: Multiple charge states (typically z = 2–5 for peptides <3 kDa) are deconvoluted using MaxEnt or similar algorithms.

MALDI-TOF MS

Principle: Peptide co-crystallized with matrix (CHCA, sinapinic acid) is desorbed/ionized by laser pulse.

Sample preparation:

1. Dissolve peptide in 0.1% TFA/H₂O (1 pmol/µL)
2. Mix 1:1 with CHCA matrix (10 mg/mL in 50% MeCN/0.1% TFA)
3. Spot 1 µL on target plate
4. Air-dry, analyze in reflectron mode

Advantages: Fast, tolerant of contaminants, minimal sample consumption.

LC-MS/MS for Peptide Sequencing

Data-dependent acquisition:

1. Full MS scan (m/z 200–2000)
2. Select top 5 most intense ions
3. Fragment by CID (collision energy 20–40 eV)
4. Acquire MS/MS spectrum
5. Database search or de novo sequencing

Common fragment ions:

• b-ions: N-terminal fragments
• y-ions: C-terminal fragments
• a-ions: Loss of CO from b-ions

2. HPLC Purity Analysis

Analytical HPLC Methods

Standard method (C18 column):

Parameter	Value
Column	C18, 2.1 × 150 mm, 1.7 µm
Solvent A	0.1% TFA/H₂O
Solvent B	0.1% TFA/MeCN
Gradient	5–65% B over 20 min
Flow	0.3 mL/min
Detection	UV 220 nm
Injection	5 µg

Purity Assessment

Area normalization: Purity = (Area of main peak / Total area) × 100%

Requirements by application:

Application	Purity	Method
Research	>95%	RP-HPLC
Preclinical	>98%	RP-HPLC + IEX
Clinical	>98.5%	RP-HPLC + IEX + CE
Commercial	>99%	Multiple orthogonal

Common Impurity Profile

Impurity	Source	% of Crude
Deletion sequences	Incomplete coupling	5–20%
Truncated sequences	Early termination	2–10%
Oxidized products	Met/Cys oxidation	1–5%
Diketopiperazine	C-terminal proline	1–3%
Racemized epimers	Base-catalyzed	0.5–2%

3. Circular Dichroism (CD) Spectroscopy

Principles

CD measures the differential absorption of left and right circularly polarized light by chiral chromophores. For peptides, the peptide bond (amide π→π* and n→π* transitions) generates CD signals in the far-UV (190–250 nm).

Secondary Structure Assignment

Structure	Characteristic Spectrum	Wavelengths
α-Helix	Strong negative at 222, 208 nm; positive at 193 nm	Two minima
β-Sheet	Negative at 218 nm; positive at 195 nm	One minimum
Random coil	Negative at ~198 nm	One minimum
β-turn	Positive at 220–230 nm	Variable

Sample Requirements

• Concentration: 0.1–0.5 mg/mL
• Buffer: Phosphate, Tris, or CD (avoid high-salt buffers)
• Path length: 0.1 cm (far-UV)
• Volume: 300 µL minimum

Temperature-Dependent CD

Monitor structural changes vs. temperature:

1. Record CD at 222 nm (α-helix) or 218 nm (β-sheet)
2. Heat from 20 to 95°C at 1°C/min
3. Calculate T_m (melting temperature) from sigmoidal fit
4. T_m > 60°C indicates stable structure

4. NMR Spectroscopy

NMR Techniques for Peptides

Technique	Information	Time	Sample
¹H 1D	Amino acid composition	5 min	1 mg
¹H-¹H TOCSY	Spin system identification	1 hr	1 mg
¹H-¹H NOESY	Through-space contacts	4–8 hr	1 mg
¹H-¹³C HSQC	Carbon assignments	2–4 hr	5 mg
¹H-¹⁵N HSQC	Amide backbone	1–2 hr	5 mg

Sample Preparation

• Concentration: 0.5–2 mM (5–20 mg/mL for 600 MHz)
• Solvent: 90% H₂O/10% D₂O (for amide protons) or D₂O
• pH: 4.0–5.0 (minimizes exchange broadening)
• Temperature: 25°C standard; variable temperature for dynamics

Structure Determination Workflow

1. Sequential assignment: TOCSY → NOESY → walk through spin systems
2. NOE assignments: Identify short-range (i, i+1) and long-range NOEs
3. Distance restraints: Convert NOE intensities to distance bounds
4. Structure calculation: Simulated annealing with distance restraints (CNS, XPLOR-NIH, CYANA)
5. Refinement: Energy minimization in explicit water (OPN, AMBER)

Quality Metrics

Parameter	Acceptable	Excellent
NOE violations	<5% >0.5 Å	<1% >0.5 Å
RMSD backbone	<2.0 Å	<1.0 Å
RMSD heavy atoms	<3.0 Å	<1.5 Å
Ramachandran favored	>80%	>90%
Ramachandran outliers	<5%	<1%

5. Additional Characterization Methods

Amino Acid Analysis (AAA)

• Hydrolysis in 6 M HCl, 110°C, 24 hr
• Derivatization and HPLC or CE analysis
• Confirms composition and stoichiometry
• Accuracy: ±5% per residue

Edman Sequencing

• N-terminal degradation cycle-by-cycle
• PTH-amino acids identified by HPLC
• Limitations: N-terminal blockage, <50 residues
• Largely replaced by MS/MS

Isoelectric Focusing (IEF)

• Separates peptides by pI
• Useful for charged peptides (Lys, Arg-rich)
• Can separate diastereomers

Analytical Ultracentrifugation

• Sedimentation equilibrium for oligomeric state
• Sedimentation velocity for shape
• No column interactions, true solution state

6. Characterization Panel by Application

Application	Required Methods
Academic research	MS + RP-HPLC (>95%)
Drug discovery	MS + HPLC + CD + AAA
Preclinical	MS + HPLC + CD + AAA + Stability
Clinical candidate	MS + HPLC + CD + NMR + AAA + ICH stability
Commercial product	All above + CE + pI + Potency

References

1. Papayannis, I., et al. “Peptide characterization by mass spectrometry.” Methods in Molecular Biology 126 (2020): 1–32.
2. Greenfield, N.J. “Using circular dichroism spectra to estimate protein secondary structure.” Nature Protocols 1 (2006): 2876–2890.
3. Wüthrich, K. NMR of Proteins and Nucleic Acids. Wiley, 1986.

Further Reading

• Mass Spectrometry for Peptides — Detailed MS methods
• Circular Dichroism — CD spectroscopy for peptides
• NMR Structure — NMR structure determination
• Quality Control — Full QC panel